Skip to main content
MNOV
NASDAQ Life Sciences

MediciNova's NAFLD Drug Trial Completes Patient Visits; Top-Line Data Expected Q3

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$1.39
Mkt Cap
$67.433M
52W Low
$1.168
52W High
$1.96
52W Position info
19% above low
Off High info
29% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

MNOV sits 19% above its 52-week low of $1.168.

Summary

MediciNova announced the completion of the last patient last visit (LPLV) in its Phase 2 clinical trial for MN-001 (tipelukast), targeting hypertriglyceridemia and nonalcoholic fatty liver disease (NAFLD) associated with type 2 diabetes. This marks a significant operational milestone, moving the trial into the data analysis phase. For a clinical-stage biopharmaceutical company, successful progression through trials is crucial. Top-line data from this trial are expected in the third quarter of 2026.

At the time of this announcement, MNOV was trading at $1.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $67.4M. The 52-week trading range was $1.17 to $1.96. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

MNOV - Latest Insights

MNOV
Nov 12, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.40
Real-time Price: $1.32 info
Change: -$0.0782 (-6%) info
Market Cap: $68.652M info
MNOV
Sep 29, 2026, 5:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.92
Real-time Price: $1.32 info
Change: -$0.5982 (-31%) info
Market Cap: $68.652M info
MNOV
Sep 28, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.41
Real-time Price: $1.32 info
Change: -$1.09 (-45%) info
Market Cap: $68.652M info
MNOV
Sep 24, 2026, 6:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.63
Real-time Price: $1.32 info
Change: -$1.31 (-50%) info
Market Cap: $68.652M info
MNOV
Jun 24, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.33
Real-time Price: $1.32 info
Change: -$0.0082 (-0.62%) info
Market Cap: $68.652M info